Intravascular lithotripsy (IVL) may offer substantial value to clinicians performing transcatheter mitral valve replacement (TMVR) on patients with severe stenosis and mitral regurgitation (MR), according to new findings published in…

Medtronic has announced that patient enrollment is officially underway for a new head-to-head global study comparing the company’s Endurant II/IIs stent graft system with Gore Medical’s Excluder AAA systems.

…

Stroke patients treated with mechanical thrombectomy (MT) face a significantly higher risk of 90-day mortality if they present with atrial fibrillation (AFib), according to a new meta-analysis published in …

AVS, a Michigan-based medical device company focused on interventional cardiology, has raised $20 million in Series B financing. The funding is expected to help AVS ramp up work on its Pulse Pulsatile-Intravascular Lithotripsy (P-IVL…

Black patients are 41% more likely than white patients to experience a prolonged length of stay after going to the hospital for acute ischemic stroke, according to a new study published in …

Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis…

Siemens Healthineers has announced Corindus, the vascular robotics company it acquired back in 2019, has been renamed Siemens Healthineers Endovascular Robotics. It is now part of the advanced therapies division within Siemens…

Medications designed to treat rheumatoid arthritis (RA) and Parkinson’s disease have been associated with key cardiovascular benefits, according to two recent studies.

The studies were unrelated and…

Fucoidan, a natural material derived from seaweed, may be able to boost cardiac surgery outcomes, according to a new analysis published in Bioactive Materials.[1] The research is still limited to small animal models thus far…

Embracing a plant-based diet can improve a person’s cardiovascular health, according to a new commentary published in the American Journal of Cardiology.[1] The article, titled “Are We What We Eat? The Moral Imperative of the…

Researchers have developed a new artificial intelligence (AI) model capable of predicting a patient’s 10-year risk of death from a heart attack or stroke—all…

CSL has announced that etranacogene dezaparvovec-drlb, the company’s new gene therapy for adult patients with hemophilia B, has been approved by the U.S. Food and Drug Administration (FDA). …

Bypass surgery is associated with fewer repeat procedures and amputations than endovascular treatment options such as angioplasty and stenting when treating patients with chronic limb-threatening ischemia (CLTI), according…

Paclitaxel drug-coated balloons (DCBs) are an effective treatment option for the treatment of femoropopliteal artery disease and femoropopliteal in-stent restenosis, according to two late-breaking clinical trials presented…

One-year mortality is more common among men undergoing transcatheter aortic valve replacement (TAVR) than women, according to new findings…

Intravascular lithotripsy (IVL) is associated with consistent improvements in patients who present with complex, heavily calcified peripheral artery disease (PAD), according to a late-breaking clinical trial presented at the…

The American College of Cardiology (ACC) has published a new guidance document focused on the treatment of patients who present with atherosclerotic cardiovascular disease (ASCVD) and other chronic…

Long-term outcomes are similar between men and women who undergo left atrial appendage occlusion (LAAO) for nonvalvular atrial fibrillation (NVAF), according to new research published in JACC: Cardiovascular Interventions.[1…

Nirmatrelvir-ritonavir (NMVr), sold by Pfizer under the name Paxlovid, is commonly prescribed to treat symptomatic COVID-19 patients, including patients who…